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To identify specific histologic abnormalities that could
predict early cardiac rejection before the development
of myocyte necrosis, 167 consecutive endomyocardial bi-
opsy samples from 18 cardiac transplant recipients were
retrospectively analyzed and 17 histologic variables were
semiquantitatively graded from 0 to 3. Forty-five biopsy
samples contained foci of myocyte necrosis and were
labeled Rejectors. The two samples immediately preced-
ing Rejector biopsies were labeled Predictors (n = 44).
All remaining samples were labeled Others (n = 78).
Endocardial and interstitial infiltrates, interstitial
mononuclear cells, pyroninophilic mononuclear cells,
polymorphonuclear leukocytes and other cells (eosino-
phils and plasma cells) were significantly increased in
graded severity in Rejector biopsy samples as compared
with Predictors or Others (p < 0.001, ANOVA testing).
These variables cannot distinguish Predictor biopsy
Since 1972, serial endomyocardial biopsies have been suc-
cessfully used to monitor cardiac transplant recipients for
episodes of acute cardiac rejection. In early cardiac trans-
plant recipients treated with conventional immunosuppres-
sive therapy (prednisone and azathioprine), clinical expe-
rience indicated that rejection episodes developed rapidly
and histologic evidence of rejection preceded clinical evi-
dence of rejection by as little as 2 to 3 days (I). Histologic
evidence of rejection was defined by the presence of inter-
stitial inflammation associated with myocyte necrosis, and
histologic evidence of severe rejection with extensive my-
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specimens from Others. On the other hand, interstitial
edema, perivascular karyorrhexis and perivascular in-
filtrate with lntermyocyte extension are histologic ab-
normalities that can distinguish Predictor biopsy sam-
ples from Others (p < 0.001, ANOVA testing). Multiple
logistic regression analysis indicates that the relative risk
of developing myocyte necrosis when a biopsy sample
contains interstitial edema is 8.1. With perivascular in-
filtrate with intermyocyte extension in addition, the rel-
ative risk is 41.4.
In summary, three histologic abnormalities have been
identified that help predict the future development of
myocyte necrosis within the next two endomyocardial
biopsies. Biopsy specimens with these abnormalities
probably represent early cardiac rejection before the
development of myocyte necrosis.
(J Am Coli Cardiol 1987;9:802-10)
ocyte necrosis; vascular necrosis was not uncommon (1-7).
In contrast, experience with cardiac transplant recipients
treated with cycIosporin and prednisone has suggested that
acute rejection episodes develop more slowly and histologic
evidence of severe cardiac rejection is seen only rarely
(3,5,6,8). The slower development of acute rejection epi-
sodes in cyclosporin-treated cardiac transplant recipients form
the basis of this study.
We retrospectively studied serial endomyocardial biopsy
specimens from 18 consecuti ve cardiac transplant recipients.
Using a semiquantitative grading system, 17 histologic ab-
normalities frequently found in posttransplantation biopsy
samples were studied. The focus of this study was to de-
termine whether endomyocardial biopsy samples that pre-
cede samples with myocyte necrosis had unique histologic
patterns of abnormalities and could therefore be distin-
guished histologically from those samples that were not
followed by the development of myocyte necrosis. Using
univariate analysis, three histologic abnormalities were
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Table 1. Histologic Variables Examined
Interstitial
Interstitial inflammation
Mononuclear cells
Pyroninophilic mononuclear cells
Polymorphonuclear leukocytes
Others (plasma cells. eosinophils)
Interstitial edema
Extravasated red blood cells
Vascular and perivascular
Perivascular inflammation. localized
Perivascular inflammation with intermyocyte extension
Perivascular karyorrhexis
Arteriolar vasculitis
Intravascular stasis
Intravascular leukocyte plugging
Endothelial cell activation
Miscellaneous
Endocardial inflammation
Myocytolysis
Cyclosporin effect
identified that could distinguish biopsy samples preceding
those with myocyte necrosis from samples that were not
followed by the development of myocyte necrosis. Multiple
logistic regression analysis then determined the relative risks
of developing myocyte necrosis for each of the three his-
tologic predictors that were identified.
Methods
Endomyocardial biopsy protocol. One hundred sixty-
seven consecutive endomyocardial biopsy samples from IX
transplant recipients were analyzed. All biopsies were per-
formed between July 1983 and January 1985. Approxi-
mately three to six endomyocardial fragments per biopsy
are routinely obtained by the internal jugular approach using
a 50 Col Stanford modified Caves catheter. All biopsies
performed within 2 weeks after increases in immunosup-
pressive therapy for acute rejection were excluded from the
study because current guidelines suggest that resolution of
acute rejection episodes in patients receiving cyclosporin
frequently takes up to 2 to 3 weeks (3,5,6,8). Biopsies that
yielded fewer than three separate endomyocardial specimens
were also excluded because there is a significant decline in
biopsy sensitivity with only two fragments (3). The semi-
Table 2. Classification of Histologic Variables
quantitative grading system was applied to all biopsy spec-
imens that contained endomyocardium. Not included were
epicardial specimens or specimens composed solely of scar
(representing previous biopsy site or healed myocytolytic
injury).
Preparation and grading of biopsy specimens. Spec-
imens were immediately placed in 10% buffered formalin,
routinely processed and stained with hematoxylin-eosin,
Masson's trichome, phosphotungsic acid hematoxylin (stain
for fibrin). methyl green pyronine (staining for active ri-
bonucleic acid synthesis to identify activated lymphoblasts)
and Verhoeff elastic stain. Each section was 5 fLm thick
and approximately five step sections were placed on each
slide. Eight slides were reviewed for each biopsy specimen
so that the majority of the tissue was sectioned and studied.
Two cardiac pathologists routinely reviewed all biopsy spec-
imens.
Criteria used to grade and define the various histologic
abnormalities analyzed in this study were established by
both pathologists. All 167 endomyocardial biopsies were
then reviewed retrospectively in a blinded fashion by one
of the cardiac pathologists (AH). Biopsy specimens were
randomly chosen from all 18 patients so that examination
of serial biopsy samples from any patient was avoided. The
biopsy samples were subjected to a semiquantitative grading
system designed to accurately describe 17 histologic vari-
ables commonly found in posttransplant biopsy samples (Ta-
ble I). The four histologic variables-localized perivas-
cular inflammation, perivascular inflammation with
intermyocyte extension, perivascular karyorrhexis and my-
ocytolysis-were quantitatively graded 0 to 3 (0 = no foci,
I = one focus, 2 = two to five foci, 3 = greater than five
foci). Interstitial edema, arterial vasculitis and cyclosporin
effect were scored as either absent or present. The remaining
10 histologic variables were subjectively graded 0 to 3 (0
= none or normal, I = mild, 2 = moderate, 3 = severe).
Examination of multiple, serial step sections was used to
determine how many distinct foci containing a graded his-
tologic variable were present.
The biopsy samples were separated into three groups
(Table 2). Biopsy samples containing foci of myocyte ne-
crosis (n = 45) represented the outcome we wanted to
predict. and were therefore called Rejectors and labeled
Group I. Samples from the two biopsies immediately pre-
ceding Group I biopsies were placed into Group 2 and called
Others
2 3
'" /Predictors
4
Rejector
5
Others
6 7
'" /Predictors Rejector
In this hypothetical patient with eight posttransplant biopsy samples. myocyte necrosis is present in biopsy
samples 4 and 8 (Rejectors. Group I l. By convention. therefore. biopsy samples 2 and 3 are labeled Predictors
(Group 2). Remaining biopsy samples I and 5 were placed in Others (Group 3).
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Table 3. Dates of Sequential Posttransplant Biopsies and Identification of Biopsy Samples With Myocyte Necrosis in 18Patients
Case No.
2
3
4
5
6
7
8
9
10
II
12
13
14
15
16
17
18
No. of Biopsy
Procedures
15
16
14
16
II
9
12
14
16
16
13
9
10
10
7
6
5
4
203
No. of Rejection
Episodes
1
2
2
3
4
1
6
2
3
7
4
3
o
3
1
I
2
2
47
Posttransplant Days of Biopsy
7.12.17.25.33,39,44,53.67.81.100.115.136,156.246*
6,10. 17.25.31.37.58.72.92,106. 128. 156,214.l!Q.329.383
8.15.22.29,36,53.72.79.97.128.188.252.300,368
8.14.19.34,48.79.86.94,.l!l. 126.140.186. 195.224.342,442
8.,lQ.23,31 ,45.54.61.75.96.I25.ill*
7..8.24.34,48.70.140.210,303
4, IO,.!1,32.~.60.66.84.106.126.160.162*
5.14.26.35,47,68,83,124.152.168.195.270.290,302
9.15.22.30.44.64.92.103.128.160.190.199.211.244.282.295
9 ..L4.20.32,44,57 ,64.B.IOO.120.149.160.182, 194.226,283
7.14.21.28.i!.70.96.114.144.155, 186.m,246
1.14.25,32,52.61,87.1 I I,ill
8.14.21.39.56.70.84, llXJ.114.146
9,.!1,24,33,47.60.B.94.108.135
7..8.21.28,35,49.64
7..!i.22.28.35,49
2,13,~.28,41
7..!j.20.28
*Died. Biopsy samples with myocyte necrosis are underlined.
Predictors. Samples from all remaining biopsies were called
Others and placed in Group 3.
Immunosuppressive protocol. All patients were main-
tained on treatment with cyclosporin A and oral prednisone
after transplantation, Cyclosporin doses were modified to
maintain a plasma level of 50 to 150 ng/ml as determined
by radioimmunoassay, Acute rejection episodes were treated
with increased oral prednisone, Solu-Medrol, antithymy-
ocyte globulin and OKT-3 depending on the frequency and
severity of rejection. One patient (Patient 9, Table 3) re-
quired substitution of Imuran for cyclosporin therapy be-
cause of persistent renal function abnormalities.
Definitions: Some Graded Variables
Require Definition
Interstitial. Interstitial edema, This edema was defined
as either I) exaggerated separation of individual myocytes
(Fig, IA) or muscle bundles (Fig. IB) by a widened inter-
stitium; the widened interstitial space must contain loosely
arranged strands of collagen that appear separated and may
appear disorganized (Fig. IA,B); or 2) interstitial fibrin
deposition as demonstrated by the phosphotungstic acid he-
matoxylin stain. The isolated finding of clear zones in either
Figure 1. Interstitial edema. A, High power photomicrograph
with wide separation of longitudinally arranged myocytes. The
interstitial space is accentuated and contains delicate strands of
collagen fibrils that appear disorganized. loosely bound and sep-
arated. Hematoxylin-eosin stain; magnification X 320. B, Me-
dium power photomicrograph displaying wide separation of myo-
cyte bundles seen in cross section. Individual collagen fibrils are
seen within theaccentuated interstitial space andappear separated.
A sparse mononuclear cell infiltrate is present. Hematoxylin-eosin
stain; magnification x 150.
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perivascular or endocardial locations which were only
suggestive of edema were not considered interstitial edema.
Although this strict definition may underestimate the true
prevalence of myocardial interstitial edema, it reduces the
rate of false positive results secondary to trauma and fixation
artifact (15).
Figure 2. Perivascular karyorrhexis. A, Small intramyocardial
vein with a sparse mononuclear perivascular infiltrate which is
localized to the immediate perivascular space. The perivascular
connective tissue is normal and there is no perivascular edema.
Hematoxylin-eosin stain; magnification x 320. B, Small zone of
perivascular (perivenous) karyorrhexis. Perivascular infiltrate is
mixed mononuclear andpolymorphonuclear. Theperivascular col-
lagen fibrils are separated, disrupted and appear basophilic and
granular. Small, round or eccentric, deeply basophilic structures
are randomly distributed within the infiltrate and may represent
nuclear fragments (arrows). Inflammatory cellsare seen todisrupt
the smooth contour of the vascular endothelium (small arrows).
Hematoxylin-eosin stain; magnification x 350. C, Similar local-
izedinterstitial collection of a predominantly mononuclear inflam-
matory cell infiltrate with wide separation and disorganization of
the interstitial collagen (arrows). Presumed nuclear debris appears
as deeply basophilic round structures (large arrows). Hematox-
ylin-eosin stain; magnification x 310. D, A small intramyocardial
vein with a mixed perivascular infiltrate. The basophilia andgran-
ular degeneration of the interstitial collagen is highlighted (ar-
rows). Hematoxylin-eosin stain; magnification x 550.
Extravasated red blood cells. These are clusters of intact
red blood cells within the interstitium or subendocardium.
Pyroninophilic mononuclear cells. These are plump
mononuclear cells that stain with methyl green pyronine
stain. These cells are believed to be lymphoblasts (immu-
noblasts) or activated lymphocytes; they are considered to
represent evidence of active, ongoing inflammation and their
presence has been used to distinguish active inflammation
from resolving inflammation (2).
Vascular and perivascular. A localized perivascular
infiltrate is shown in Figure 2A.
Perivascular karyorrhexis. This is a mixed, perivenous
infiltrate containing both mononuclear and polymorphonu-
clear leukocytes that contain the following characteristics:
A) Localized edema of the perivascular space that contains
I) separated mononuclear and polymorphonuclear inflam-
matory cells (Fig. 28 and C), 2) disrupted and separated
collagen fibrils that appear basophilic and granular (Fig. 28,
C and D), and 3) deeply basophilic round structures, sig-
nificantly smaller than nuclei of the mononuclear inflam-
matory cells which are believed to represent nuclear debris
(Fig. 28 and C). 8) Localized disruption of the vascular
endothelium by the inflammatory cells (Fig. 28 and D).
Perivascular infiltrate with intermyocyte extension. This
consists of fingerlike projections of inflammatory cells that
extend past the localized perivascular space into adjacent
,-.-.
• ••.,
806 HERSKOWITZ ET At.
HISTOLOGIC PREDICTORS OF CARDIAC REJECTION
JACC Vol. 9. No.4
April 1987:802-10
myocardium, separating individual myocytes (Fig. 3A and
B).
Arterial vasculitis. This consists of transmural or intra-
mural collections of inflammatory cells within arterioles
present within zones of myocardium. Arterioles within dense
scar were not considered.
Intravascular stasis. This consists of clumps of coin-
stacked red blood cells filling capillaries and venules.
Intravascular leukocyte plugging. This is defined as the
presence of leukocytes filling the lumen of capillaries or
venules frequently associated with clusters of coin-stacked
red blood cells. These two latter variables were believed to
possibly represent indirect evidence of microvascular stasis.
Endothelial cell activation. This is manifested as plump
endothelial cells with prominent nucleoli that protrude into
the lumen of arterioles and venules frequently occupying a
considerable portion of the vessel lumen. These cells are
believed to represent indirect evidence of antigen stimula-
tion (9).
Figure 3. Perivascular infiltrate with intermyocyte extension. A,
Medium power photomicrograph showing a moderate perivascular
infiltrate that is no longer localized to the immediate perivascular
space. Stellate projections of mononuclear cells extend into ad-
jacent myocytes. Hematoxylin-eosin stain; magnification x 220.
B, Perivascular infiltrate with finger-like extensions of mononu-
clear inflammatory cells into adjacent intermyocyte spaces. He-
matoxylin-eosin stain; magnification x 150.
Miscellaneous. Myocytolysis. This is manifested as: a)
discrete zones of loose, organized connective tissue con-
taining scattered mononuclear cells and fibrocytes. Mono-
nuclear cells are frequently pigment laden. b) Zones of
myocardium where myocytes appear as hollow tubes with
empty cytoplasm and intact sarcolemmal sheaths. These
abnormalities are believed to represent zones of myocyte
dropout due to a nonspecific injury, frequently seen in re-
solving reperfusion injury.
To test the intraobserver variability for diagnosing in-
terstitial edema using the defined criteria, all 167 biopsy
samples were reviewed blindly a second time by the same
pathologist (AH), specifically noting the presence or ab-
sence of interstitial edema. The reliability coefficient was
0.84.
Statistical analysis. Chi-square analysis and analysis of
variance (ANOVA) testing with Neuman-Keuls multiple
range test were used to determine which variables differed
significantly among the three biopsy groups. To determine
which of the variables associated with the Predictor group
were indeed independent predictors of early rejection, mul-
tivariate analysis using stepwise multiple logistic regression
was performed. The regression coefficients from this anal-
ysis were used to estimate the relative risk for each of the
significant histologic variables identified.
Results
Patients. Biopsy schedules and identification of rejec-
tion episodes in our 18 patients are listed in Table 3. The
mean number of endomyocardial fragments analyzed for
each biopsy sample was 4.0. Forty-seven separate biopsy
samples contained foci of myocyte necrosis, although two
samples (from Patients 7 and 10) were not counted because
they were taken within 2 weeks of institution of immuno-
suppressive therapy. Of these 47 patients with biopsy sam-
ples consistent with moderate rejection, 43 responded to
increases in immunosuppressive therapy. Two patients died
of irreversible acute rejection (Patients 5 and 7) and one
patient died from a cerebrovascular event (Patient I).
Significant histologic variables; univariate analysis
(Table 4). Of the 17 histologic variables examined,
ANOVA testing identified nine that demonstrated statisti-
cally significant differences among the three groups. Vari-
ables I to 6 (endocardial and interstitial infiltrates, interstitial
mononuclear cells. pyrininophilic mononuclear cells. poly-
morphonuclear leukocytes and other cells [eosinophils and
plasma cells]) were significantly increased in graded severity
in Rejector biopsies as compared with Predictors or Others.
These six variables, however, could not distinguish Predic-
tor biopsy samples from Others. On the other hand, variables
6 to 9 (interstitial edema, perivascular karyorrhexis and
perivascular infiltrate with intermyocyte extension), al-
though also significantly increased in Rejector biopsy sam-
JACC Vol. 9, No.4
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Table 4. Graded Severity of Significant Histologic Variables in 167 Biopsy Samples*
Group I Group 2 Group :1
Rejectors Predictors Others
(n = 45) (n = 44) (n = 78)
I. Endocardial infiltratet 1.21 :+: 1.04 0.48 :+: 073 0.43 ± 0.58
2. Interstitial infiltratet UC :+: 0.58 0.89 ± 0.65 0,83 ± 0.7\
3. Mononuclear cellst 1.80 ± 0.59 1.00 ± 0.52 0.87 ± 0.61
4. Pyrininophilic mononuclear cells! 0.98 ± 0.82 0.40 ± 0.65 0.32 ± 0.52
5. Polymorphonuclear leukocytes! 1.34 ± 0.71 0.58 ± 0.54 0.45 ± 0.55
6. Others (eosinophils, plasma cellsrt 050 :+: 0.79 0.22 ± 0.56 0.13 ± 0.37
7. Perivascular karyorrhexis] 1.75 ± 1.12 0.73 ± 0.84 0.29 ± 0.70
8. Perivascular infiltrate with IlJ3 ± 0.93 0.78 ± 0.82 0.41 ± 0.71
intermyocyte extensiont
9. Interstitial cdernat 032 ± 0.60 0.27 ± 0.44 0.01 ± 0.11
"Analysis of variance testing with Neuman-Keuls multiple range test. 'rGroup I > Group 2,:1, p < (l.OOI:
t Group I > Group 2,3, p < (l.OO!: Group 2 > Group 3, p < 0.001.
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pies, could distinguish Predictors (Group 2) from Others
(Group 3) and therefore might predict which biopsysamples
reflect high risk for the future development of myocyte
necrosis,
Multivariate analysis (Table 5). When these three vari-
ables (6 to 9) were analyzed simultaneously by stepwise
multiple logistic regression, interstitial edemawasthestrongest
single predictor of future myocyte necrosis over the next
two biopsies, Perivascular karyorrhexis was not additively
predictive, Perivascularinflammation with intermyocyte ex-
tension was an independentand additive factor that predicts
future myocyte necrosis over the next two biopsies (Table
5A), The relative risk (the measure of the likelihood of
rejection in patients displaying each significant variable as
compared with the likelihood in those patients without the
variable) of rejection with a biopsy sample with interstitial
edema is 8,05, with perivascularinfiltrate with intermyocyte
extension, 5.14, and with both these variables. 41.38.
In an attempt to determine how these histologic abnor-
malities differ in significance over time, a separate series
of analyses were made. One analysis was confined to only
those Predictor biopsy samples taken two biopsies before
the development of myocyte necrosis. This analysis ex-
cluded the biopsy samples obtained immediately preceding
a Rejector biopsy sample. The mean number of days be-
tween these biopsy samples and the next Rejector biopsy
sample was 40.2. This analysis was designed to isolate the
earliest histologic abnormalities predictive of future my-
ocyte necrosis. This analysis revealed that both interstitial
edema and a moderate grade (grades 2 or 3) of perivascular
infiltrate with interrnyocyte extension were the early inde-
pendent and additive factors predictive of future myocyte
necrosis(Table 58) and had a relative risk of 2.62 and 2.11,
respectively. In this analysis. a biopsy specimen with both
these variables indicated a 5.5-fold increased risk that my-
ocyte necrosis would develop in the second future biopsy,
Table 5. Results From Multiple Stepwise Logistic Regression of Significant Histologic
Variables Distinguishing Predictors From Others
Factor Coefficient p Value Relative Risk
A. Interstitial edema 2()853 0.007 8.05
Perivascular infiltrate with 1.6376 0.075 5.\4
intermyocyte extension"
Botht 41.38
B. Interstitial edema 0.96384 0.011 2.62
Perivascular infiltrate with 0.74466 0.021 2.11
intermyocyte extension"
Botht 5.5
C. Interstitial edema 18231 0.001 6.2
Perivascular karyorrhexis" 0.61985 0.032 :1.5
Botht 21.4
*Grade 2 or 3 (2 to 5 foci or >5 foci). tBoth histologic variables present in the same biopsy specimen.
A: Multiple stepwise logistic regression using all Predictor biopsy samples: B: Multiple stepwise logistic
regression using only those Predictor biopsy samples taken two biopsies before the development of myocyte
necrosis: C: Multiple stepwise logistic regression using only those Predictor biopsy samples taken immediately
before the development of myocyte necrosis.
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Table 6. Specificities, Sensitivities and Predictive Values of Various Combinations of the
Significant Histologic Variables That Distinguish Predictors From Others
Positive Negative
Specificity Sensitivity Predictive Predictive
(%) (%) Value Value
A. Interstitial edema 93 46 81% (22/27) 83%
Perivascular karyorrhexis* 92 25 67% (12118) 77%
Perivascular infiltrate with 93 25 71% (12117) 85%
intermyocyte extension*
B. Interstitial edema or 88 59 64 86%
perivascular karyorrhexis*
Interstitial edema or 87 50 44 89%
perivascular infiltrate with
intermyocyte extension*
C. Interstitial edema and 97 13 75% (6/8) 75%
perivascular karyorrhexis*
Interstitial edema and 100 15 100% (717) 84%
perivascular infiltrate with
intermyocyte extension"
*Grade 2 or 3 (2 to 5 foci or >5 foci).
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as compared with a biopsy sample without these two vari-
ables.
When a similar multiple logistic regression analysis was
confined to only those biopsies that immediately preceded
Rejector biopsies (mean interval 18 days), both interstitial
edema and perivascular karyorrhexis appeared as later in-
dependent and additive factors that predict future myocyte
necrosis (Table 5C). A biopsy sample with both interstitial
edema and a moderate grade (grades 2 or 3) of perivascular
karyorrhexis carried a relative risk of 21.4.
The utility of these three histologic variables as predic-
tors of subsequent rejection can be assessed by the four
measures presented in Table 6. The sensitivities, specific-
ities and positive and negative predictive values of these
predictive variables are listed for various combinations of
the variables.
Discussion
We have identified three histologic abnormalities found
in endomyocardial biopsy samples from cardiac transplant
recipients tliat help distinguish patients whose biopsies show
development of myocyte necrosis from those who do not.
Of the 17 histologic variables analyzed, interstitial edema,
perivascular karyorrhexis and perivascular inflammation with
intermyocyte extension are significantly increased in those
biopsies preceding biopsies manifesting myocyte necrosis.
Prediction of acute cardiac rejection. The ability to
diagnose episodes of acute cardiac rejection as early as
possible has immediate practical benefits. Early cardiac re-
jection may be reversed with smaller doses of immunosup-
pressive agents over a shorter time period. This may result
in both a reduction in the amount of permanent damage to
the heart and a lowered risk of infection in the immuno-
suppressed recipients. In the early 1970s when cardiac trans-
plant recipients received prednisone and azathioprine, re-
jection episodes developed rapidly and histologic evidence
of rejection preceded clinical evidence of rejection by as
little as 2 to 3 days (I). Histologic evidence of rejection
was defined as the presence of interstitial inflammation in
association with myocyte necrosis. The rapid development
of extensive myocyte necrosis and vascular necrosis was
not uncommon (1-7). In contrast, experience with cardiac
transplant recipients receiving cyclosporin and prednisone
has suggested that rejection episodes are slower to develop
and histologic evidence of severe cardiac rejection with
extensive myocyte and vascular necrosis is only seen in the
most extensive and potentially irreversible episodes of re-
jection (3,5--8). The slower development of rejection epi-
sodes has allowed specific histologic abnormalities to be
identified that can predict future development of myocyte
necrosis and thereby diagnose cardiac rejection at an early
stage.
Of the 167 consecutive endomyocardial biopsy samples
examined, 45 were consistent with moderate acute rejection
containing both active interstitial inflammation and foci of
myocyte necrosis. The remaining 122 did not contain foci
of myocyte necrosis. Of these remaining samples, those with
interstitial edema or two or more foci of perivascular kar-
yorrhexis or perivascular inflammation with intermyocyte
extension, or both, could distinguish biopsy samples with
abnormalities leading to myocyte necrosis from other sam-
ples with nonspecific histologic abnormalities.
Interstitial edema. Interstitial edema is a common fea-
ture of acute cardiac rejection both in humans and in ex-
perimental models of rejection (9-13). It is a manifestation
of a primary immunologic injury to the microvascular bed
that produces a vascular leak. One of the earliest changes
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observed in acute rejection in patients receiving conven-
tional immunosuppression with prednisone and azathioprine
was the development of interstitial edema, particularly in a
perivascular location (1,3,6). In our study, interstitial edema
also appears to be the earliest and most sensitive histologic
marker of injury leading to acute rejection. The presence
of interstitial edema on a random biopsy specimen without
myocyte necrosis indicated an 81% chance (22 of 27 cases)
that myocyte necrosis would develop within the next two
biopsies. Unfortunately, no practical marker for the pres-
ence of interstitial edema on light microscopic examination
of endomyocardial biopsy tissue is available. Interstitial fi-
brin deposition as is usually documented by the phospho-
tungstic acid hematoxylin stain is not helpful because acute
rejection appears to be a fibrinolytic state (14) and positive
staining is rarely seen. Because the endomyocardial biopsy
fragments are fragile and subject to tissue and trauma artifact
(15), extreme caution must be used in defining interstitial
edema histologically. Therefore, in this study, interstitial
edema was defined to be present only when there was both
wide separation of individual muscle bundles or individual
myocytes in association with wide separation and dispersion
of interstitial collagen fibrils in more than one biopsy frag-
ment. Using these criteria interstitial edema was diagnosed
with a reliability coefficient of 0.84.
Perivascular abnormalities. The pathophysiologic sig-
nificance of perivascular karyorrhexis and perivascular in-
flammation with intermyocyte extension is not known, but
both of these abnormalities appear to be predictive features
of ongoing acute cardiac inflammation leading to cardiac
rejection. Biopsy samples in this study were not examined
by electron microscopy but lesions resembling perivascular
karyorrhexis seen in hearts with lethal rejection at autopsy
have shown that these perivascular inflamed foci frequently
contain fibrin and cellular and nuclear debris (unpublished
data), This is possibly due to a significant injury to the
endothelium of the microvasculature adjacent to the in-
flamed focus. Perivascular inflammation with intermyocyte
extension has been described both as a feature of early
allograft rejection in a cyclosporine-treated rat allograft model
( 13) as well as a predictor of acute rejection in humans ( I).
It is, therefore, of great importance to carefully characterize
the pattern of perivascular inflammation in every biopsy
sample, because both localized perivascular inflammation
and perivascular inflammation without the characteristics
described for perivascular karyorrhexis may be nonspecific
findings.
Nonspecific mild rejection. A commonly used defini-
tion of mild rejection is the presence of a scant interstitial
and perivascular mononuclear cell infiltrate without asso-
ciated focal myocyte necrosis (1,2,6). Cardiac transplant
centers commonly report that only one-third to one-half of
biopsy samples manifesting mild rejection are succeeded by
biopsy specimens showing progression to moderate rejec-
tion. In this study, 37% (31 of 84) of our biopsy samples
with mild rejection as broadly defined presage progression
to moderate rejection with myocyte necrosis. The 53 biopsy
samples with mild rejection that were not followed by pro-
gression to moderate rejection contained mild or moderate
grades of interstitial inflammation and 24 of these 53 sam-
ples had single foci of perivascular karyorrhexis or peri-
vascular inflammation with intermyocyte extension, or both.
Our study demonstrates that in cyclosporin-treated patients,
interstitial and endocardial inflammation, localized perivas-
cular infiltrates and single foci of perivascular karyorrhexis
and perivascular inflammation with intermyocyte extension
all fail to predict the future development of moderate re-
jection with myocyte necrosis. This suggests that these find-
ings are commonly seen in biopsy samples from cyclo-
sporin-treated patients and may be nonspecific. It seems
significant, though, that because a single focus of perivas-
cular karyorrhexis or perivascular inflammation with inter-
myocyte extension, or both, appears as a nonspecific feature
of mild rejection, the presence of two or more distinct foci
(grades 2 to 3 on the semiquantitative scale) reflects a more
generalized inflammatory process that can be used to iden-
tify high risk Predictor biopsy samples with a specificity of
>90% (Table 6).
Significant histologic variables: multivariate analysis.
When all Predictor biopsy samples are analyzed together,
both interstitial edema and perivascular infiltrate with in-
termyocyte extension appear to be independent and additive
factors predictive of future myocyte necrosis (Table SA).
A sample with both these factors carries a relative risk of
future myocyte necrosis of 41.38. Although these factors
appear to be the early histologic expressions of cardiac re-
jection, perivascular karyorrhexis becomes an independent
and additive factor at a later time and when present appears
to be predictive of myocyte necrosis on the immediate en-
suing biopsy sample (Table 5C). A biopsy sample with both
interstitial edema and perivascular karyorrhexis carries a
relative risk of myocyte necrosis on the next biopsy of 21.4.
Sensitivity of predictive histologic variables. Despite
the high specificity of the three predictive histologic vari-
ables, only half of the Predictor biopsy samples contained
either interstitial edema or two or more foci of perivascular
karyorrhexis or perivascular inflammation with intermy-
ocyte extension (Table 6). This low sensitivity indicates that
only one-half of biopsy samples preceding a moderate re-
jection episode contain predictive histologic abnormalities
examined in this study. This is more likely due to either an
insensitivity of histology to identify some features of early
rejection or the fact that some rejection episodes develop
too quickly to be identified in their earliest stages.
Conclusions. Our data support the view that there is a
continuum of histologic abnormalities in acute cardiac re-
jection. Although sparse collections of endocardial, inter-
stitial and perivascular infiltrates are common in cycle-
sporin-treated patients, they are nonspecific findings that
may not reflect early rejection (1,2,6). Only when an acute
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episode of rejection is well established with myocyte ne-
crosis already present, are some of these variables (inter-
stitial and endocardial infiltrates, interstitial mononuclear
cells, pyrininophilic cells, polymorphonuclear leukocytes
and eosinophils and plasma cells) increased significantly
when compared with biopsy samples with mild rejection.
Biopsy samples with these findings therefore reflect non-
specific histologicabnormalities whenseen in isolation. The
presence of interstitial edema, though, appears to be a strong,
early predictor of future myocyte necrosis. Similarly, peri-
vascular infiltration with intermyocyte extension is an ad-
ditive and independent early predictor, whereas a similar
grade of perivascular karyorrhexis appears as a later pre-
dictor of future myocyte necrosis. The presence of these
histologic findings on random endomyocardial biopsy sam-
ples is a highly specific predictorof future myocyte necrosis
and therefore probably represents evidence of early cardiac
rejection.
Our data suggest that biopsy samples with interstitial
edema or two or more foci of either perivascular karyor-
rhexis or perivascular inflammation with intermyocyte ex-
tension warrant close follow-up and long intervals between
biopsies are to be avoided. Biopsy samples with interstitial
edema and either two or more foci of perivascular karyor-
rhexis or perivascular infiltrate with intermyocyte extension
can be considered evidence of early cardiac rejection and
an indication for institutionof immunosuppressive therapy.
We acknowledge Pam Hill for her assistance in preparingand editing this
manuscript.
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